Published in Br J Cancer on October 10, 2006
Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence. PLoS One (2016) 1.40
Effective modulation of CD4(+)CD25 (+high) regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2. Cancer Immunol Immunother (2012) 0.83
Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines. Front Oncol (2014) 0.80
A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapies. J Vis Exp (2014) 0.78
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med (2001) 11.73
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol (1999) 8.46
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet (2001) 6.24
The changing natural history of renal cell carcinoma. J Urol (2001) 4.72
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol (2002) 2.91
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. J Clin Oncol (2003) 2.22
Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int (1999) 2.19
Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer (2003) 2.18
Overview of interleukin-2 function, production and clinical applications. Cytokine (2004) 1.86
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol (2003) 1.49
Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study. J Clin Oncol (2001) 1.47
Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. Clin Cancer Res (2004) 1.31
Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma. Cancer Immunol Immunother (2004) 1.12
Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer (2001) 1.03
Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival. Br J Cancer (2002) 1.00
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer (1999) 0.99
Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery. Eur Urol (2001) 0.94
Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res (2000) 0.93
Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma. Br J Cancer (2003) 0.85
Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology (1996) 0.84
Interleukin-2 (IL-2) augments host cellular immune reactivity in the perioperative period in patients with malignant disease. Eur J Surg Oncol (1995) 0.84
The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma. Cancer (2004) 0.84
Pretreatment with interleukin-2 modulates peri-operative immuno-dysfunction in patients with renal cell carcinoma. Eur Urol (2002) 0.83
Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma: a consecutive study. Eur Urol (2005) 0.81
[Perioperative immune modulation in renal cell carcinoma--review of the current situation]. Aktuelle Urol (2003) 0.78
Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients. Oncology (1992) 0.77
Complex perioperative immuno-dysfunction in patients with renal cell carcinoma. J Urol (2001) 0.77
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol (2004) 2.73
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation (1999) 2.05
Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. Circ Res (1994) 2.04
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension (2001) 1.84
A MAP kinase necessary for receptor-mediated activation of adenylyl cyclase in Dictyostelium. J Cell Biol (1995) 1.77
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
[The cardiovascular risk factor in obesity]. Dtsch Med Wochenschr (2000) 1.73
Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation (2000) 1.73
Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract (2007) 1.69
Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation (1998) 1.69
Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest (2002) 1.67
Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation (1999) 1.67
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Protection against osmotic stress by cGMP-mediated myosin phosphorylation. Science (1996) 1.55
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. Int J Cardiol (2013) 1.55
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods. J Thromb Haemost (2003) 1.54
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol (2001) 1.51
The pelvic plexus and antireflux surgery: topographical findings and clinical consequences. J Urol (2001) 1.49
Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J (2001) 1.46
Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss. Br J Dermatol (2012) 1.44
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation (2001) 1.43
[New findings on the action of HMG-CoA-reductase inhibitors]. Dtsch Med Wochenschr (1997) 1.42
Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure. Eur Heart J (2002) 1.41
Xamoterol and the failing heart. Lancet (1989) 1.41
Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation (2000) 1.41
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke (2000) 1.40
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. Dtsch Med Wochenschr (1999) 1.39
[Clinical features and current treatment of hypertensive crisis]. Dtsch Med Wochenschr (2003) 1.39
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. Dtsch Med Wochenschr (1998) 1.39
[Atrial fibrillation]. Dtsch Med Wochenschr (2006) 1.39
[Preoperative cardiovascular risk evaluation--diagnosis]. Dtsch Med Wochenschr (2004) 1.39
[Statins as new therapeutic possibility in osteoporosis?]. Dtsch Med Wochenschr (2001) 1.38
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A. Oncogene (2007) 1.28
Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A (1999) 1.25
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation (1997) 1.23
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation (1998) 1.16
Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol (2001) 1.16
Diagnostic potential of virtual cystoscopy of the bladder: MRI vs CT. Preliminary report. Eur Radiol (2002) 1.16
Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens (2009) 1.16
Physician gender is associated with the quality of type 2 diabetes care. J Intern Med (2008) 1.15
Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation (2001) 1.14
Three-dimensional patterns and redistribution of myosin II and actin in mitotic Dictyostelium cells. J Cell Biol (1997) 1.14
Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation (1996) 1.14
Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol (1997) 1.13
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol (1996) 1.12
Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol (1998) 1.10
Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol (1994) 1.10
Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension (1995) 1.09
Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas. J Thromb Haemost (2004) 1.08
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol (1996) 1.07
Cardiovascular risk, drugs and erectile function--a systematic analysis. Int J Clin Pract (2011) 1.07
Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium. Br J Pharmacol (2000) 1.07
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol (2003) 1.07
What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06
Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J (1990) 1.06
Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation (2001) 1.05
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04
Effects of DPP-4 inhibition on cardiac metabolism and function in mice. J Mol Cell Cardiol (2011) 1.02
Stage-specific tyrosine phosphorylation of actin in Dictyostelium discoideum cells. J Cell Sci (1992) 1.01
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol (1997) 1.01
[Characteristics of patients with coronary ectasias with and without stenotic coronary artery disease]. Dtsch Med Wochenschr (2005) 1.01
Application of cell culture for the production of bioactive compounds from sponges: synthesis of avarol by primmorphs from Dysidea avara. J Nat Prod (2000) 1.01
The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol (1992) 1.00
Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene (1996) 1.00
Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. J Pharmacol Exp Ther (1984) 1.00
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma. Anticancer Res (1999) 0.98
Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells. Circulation (2000) 0.98
Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting. Z Kardiol (2003) 0.98
Effect of beta-blockers on free radical-induced cardiac contractile dysfunction. Circulation (1999) 0.97
Alcohol and the risk of myocardial infarction. Basic Res Cardiol (2001) 0.97
Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.97
Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene (1999) 0.96
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. Clin Nutr (2006) 0.96
Idiopathic eruptive macular pigmentation in a 7-year-old girl: case report and discussion of differences from erythema dyschromicum perstans. Br J Dermatol (2007) 0.95
Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol (1999) 0.95
Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest (1990) 0.95
Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation (1993) 0.95
Purification, functional characterization, and cDNA sequencing of mitochondrial porin from Dictyostelium discoideum. J Biol Chem (1992) 0.95
Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther (1997) 0.95
The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95
Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy. Hypertension (1997) 0.94
Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol (2005) 0.94
Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res (2008) 0.94
Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes. Oncogene (2006) 0.94
Thiol-proteindisulfide-oxidoreductase (proteindisulfide isomerase): a new plasma membrane constituent of mature human B lymphocytes. Scand J Immunol (1994) 0.93
The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension (1997) 0.93
Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med (Berl) (1996) 0.93
Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med (2000) 0.93
The role of heart rate in the development of cardiovascular disease. Clin Res Cardiol (2007) 0.92
[Malignant solitary fibrous tumour of the kidney: report of a case and cumulative analysis of the literature]. Aktuelle Urol (2012) 0.92